Conclusions
COVID-19 is associated with an increased risk of flares in patients with
chronic ITP within the first week of symptoms and up to three weeks in
some cases. ITP flares can be considered a poor prognostic factor. A
complete response to systemic steroids is expected in the majority of
cases.